The present invention is directed towards methods for therapeutically targeting circulating tumor cells during hemodialysis.

A portable adapter is provided that can include a closure system configured to control the flow of blood and/or dialysate between the adapter and a blood treatment apparatus. Modular systems are also provided that include the portable adapter engaged with various units such as a portable blood processing module, a non-portable base module, and/or a remote module. Methods of conducting blood treatments such as blood circulation, hemodialysis, and hemofiltration, hemodiafiltration, using the modular systems are also provided. The systems, units, and methods enable the engagement and disengagement of the adapter from the various units to conduct, interrupt, and resume blood treatments without disconnecting the adapter from the vasculature of a patient. Modular systems including interchangeable portable and base modules configured for various blood treatments are also provided that can be engaged and disengaged with each other without disconnecting the portable module from the vasculature of a patient.

An implantable or wearable kidney enclosure that is cylindrical, ovoid, or otherwise non-angular e.g., not rectangular or cuboid), having a circular or oval hemofilter that provides a blood flow pattern from an internal, central artery source radially outwards. Due to the efficient flow of the circular filter design, the enclosure can be made in a cylindrical low profile shape, resulting in a compact enclosure highly suitable for implantable and wearable dialysis applications.

An implantable device is for the selective removal of molecules from tissues or fluids so as to allow the selective removal of a particular molecule of interest (target molecule) from any type of fluid solution or tissue, including biological tissues or fluids. The device operates through the complementary action of specific-binding molecules (antibodies) directed against the target molecule inside the device. The device includes a nanoperforated membrane having pores larger than the target molecule but smaller than the antibodies, such that the fluid can be removed through a second catheter with a lower concentration of target molecules.

The present disclosure relates to a blood hose set, or to an extracorporeal blood circuit, for a single-needle treatment. In some embodiments, the set includes: a patient hose line and a Y-shaped connector or three-way connecter, which is connected to the patient hose line.In some embodiments, the blood hose set does not include any single-needle chamber in a blood path or on a blood side, nor is it connected to any single-needle chamber provided in a blood path or on a blood side. The present disclosure further relates to a control device or closed-loop control device, a blood treatment apparatus, a method for the single-needle treatment, a digital storage medium, a computer program product and a computer program.

An extracorporeal blood treatment apparatus is provided comprising a filtration unit connected to a blood circuit and to a dialysate circuit; a control unit is configured for calculating a sodium concentration value for the blood; the estimation of the sodium concentration includes the sub-step of calculating the sodium concentration value as an algebraic sum of a main contribution term based on the isoconductive sodium concentrate and of an offset contribution term based on a concentration of at least a substance in the dialysis fluid chosen in the group including bicarbonate, potassium, acetate, lactate, citrate, magnesium, calcium, sulphate and phosphate.

Embodiments disclosed herein are directed to a system including an intravenous (IV) pump, a vascular access device (VAD), securement devices, and methods thereof. The intravenous (IV) pump, vascular access device (VAD), and securement device can include a sensor, printed circuit board (PCB), communication module, and the like to determine the characteristics of the VAD device in use, the fluid being administered, and physiological characteristics of the patient. The pump unit can utilize this information to modify the flow characteristics of the fluid being administered. The VAD characteristics can be predetermined and stored on the VAD, derived from sensors, or derived from remote databases using a unique identifier. Fluid and physiological characteristics can be determined from sensors located on the pump, VAD, securement device or combinations thereof.

A disposable fluid pump is provided with a housing including first and second faces, with a sidewall extending between the first and second faces. The housing defines a chamber, with an inlet and an outlet in fluid communication with the chamber. An impeller is rotatably mounted within the chamber and includes a plurality of flexible vanes. Such a pump may be incorporated into a disposable fluid flow circuit that is adapted to be mounted on a durable hardware for processing a fluid. In such a fluid flow circuit, the fluid pump may be integrated into a cassette of the circuit or, alternatively, the inlet and outlet of the fluid pump may be directly connected to fluid flow conduits of the circuit.

The invention relates to a dialysis machine having two hydraulic connectors at the dialyzate side to which a respective connection line having a filter coupling is connected for connection to a dialyzer, with the hydraulic connectors being an inflow connector for feeding fresh dialysis liquid to the dialyzer and an outflow connector for draining consumed dialyzate from the dialyzer, and having two parking positions associated with the respective hydraulic connectors for storing the filter couplings when not in operation, wherein the inflow connector and the parking position associated with the outflow connector are arranged spaced apart from one another at the machine and the length of the connection line connected to the inflow connector is smaller than this spacing, and wherein the outflow connector and the parking position associated with the inflow connector are arranged spaced apart from one another at the machine and the length of the connection line connected to the outflow connector is smaller than this spacing.

An extracorporeal blood treatment apparatus is provided comprising a filtration unit (2) connected to a blood circuit (17) and to a dialysate circuit (32); a control unit (12) is configured for calculating a sodium concentration value for the blood; the estimation of the sodium concentration includes the sub-step of calculating the sodium concentration value as an algebraic sum of a main contribution term based on the isoconductive sodium concentrate and of an offset contribution term based on a concentration of at least a substance in the dialysis fluid chosen in the group including bicarbonate, potassium, acetate, lactate, citrate, magnesium, calcium, sulphate and phosphate.